{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:18:40Z","timestamp":1788412720756,"version":"build-2803163510"},"reference-count":69,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"DOI":"10.1080\/14737167.2026.2719624","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T07:19:08Z","timestamp":1786778348000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Protecting the patient in value-based pricing schemes"],"prefix":"10.1080","author":[{"given":"Laura","family":"Levaggi","sequence":"first","affiliation":[{"name":"Free University of Bolzano-Bozen","place":["Bolzano-Bozen, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Levaggi","sequence":"additional","affiliation":[{"name":"University of Brescia","place":["Brescia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"crossref","unstructured":"Frech H Pauly M Comanor W et al. Pharmaceutical pricing and R&D as a global Public Good [Internet]. Report No.: 31272. Available from Cambridge (MA); 2023 [cited 2026 May 11]. Available from: http:\/\/www.nber.org\/papers\/w31272.pdf","DOI":"10.3386\/w31272"},{"key":"e_1_3_4_3_1","unstructured":"Aitken M Kleinrock M Pritchett J. (IQVIA). 2024."},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046917"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2019.1552137"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2016.1223543"},{"key":"e_1_3_4_7_1","doi-asserted-by":"crossref","unstructured":"Mulcahy AW Schwam D Lovejoy SL. International prescription drug price comparisons: estimates using 2022 data [Internet]. International prescription drug price comparisons: estimates using 2022 data. Santa MoniCA (CA): RAND Corporation; 2024 [cited 2026 May 12]. Available from: https:\/\/www.rand.org\/pubs\/research_reports\/RRA788-3.html","DOI":"10.7249\/rhq-11-03-05"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-024-01731-w"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.05.006"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/520609a"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2825"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-09095-2"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-022-00737-w"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00561-6"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S551402"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.788"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0696-4"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1705035"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.4871"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-021-01274-4"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/jphsr\/rmab043"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy12020050"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-019-00541-z"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00171"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1257\/jel.20161327"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.4112"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1787\/6e5e4c0f-en"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.12.008"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-021-01050-5"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2020.1792295"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2026.1803870"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1515\/bejeap-2023-0150"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.1603"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X98018002S06"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.1249"},{"key":"e_1_3_4_36_1","unstructured":"Claxton K Sculpher M Carroll S. Value-based pricing for pharmaceuticals: its role specification and prospects in a newly devolved NHS [Internet]. Centre for health economics. York. 2011 [cited 2026 Aug 22]. Report No.: 060cherp. Available from: https:\/\/ideas.repec.org\/p\/chy\/respap\/60cherp.html"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.1566"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2008.12.010"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200826090-00004"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta19140"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2023.11.008"},{"key":"e_1_3_4_42_1","unstructured":"Markus G Kirstie S. Success multiplied: launch excellence for Multi-Indication assets | IQVIA [Internet]. 2023 [cited 2026 May 20]. Available from: https:\/\/www.iqvia.com\/library\/white-papers\/success-multiplied-launch-excellence-for-multi-indication-assets"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1287\/mnsc.2019.3574"},{"issue":"11","key":"e_1_3_4_44_1","doi-asserted-by":"crossref","first-page":"7506","DOI":"10.1287\/mnsc.2022.01721","article-title":"Indication-Based pricing for Multi-Indication drugs","volume":"70","author":"Adida E","year":"2023","unstructured":"Adida E. Indication-Based pricing for Multi-Indication drugs. Manage Sci [Internet]. 2023 [cited 2026 May 12];70(11):7506\u20137523.","journal-title":"Manage Sci"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-024-01448-x"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seps.2024.101870"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-020-00972-w"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1744133111000016"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-019-00838-w"},{"key":"e_1_3_4_50_1","doi-asserted-by":"crossref","unstructured":"Barros P Righetti G S\u00e1 L. Pricing Multi-Indication Drugs: Endogenous Patient Selection Price Caps and the Cost of Public Funds (SSRN). 2025. http:\/\/dx.doi.org\/10.2139\/ssrn.5374679","DOI":"10.2139\/ssrn.5374679"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.03.005"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2012.10.002"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200826070-00002"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2009.00510.x"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.976"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-019-00517-z"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10729-021-09587-9"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2013.11.048"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.1625"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.13235"},{"issue":"2","key":"e_1_3_4_61_1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s41669-017-0044-1","article-title":"Risk-Sharing agreements in the EU: a systematic review of Major trends","volume":"2","author":"Piatkiewicz TJ","year":"2017","unstructured":"Piatkiewicz TJ, Traulsen JM, Holm-Larsen T. Risk-Sharing agreements in the EU: a systematic review of Major trends. Pharmacoecon Open. 2017 [cited 2026 May 14];2(2):109\u2013123.","journal-title":"Pharmacoecon Open"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-020-00943-1"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-021-01070-1"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.121.007993"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.4033"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.11.1376"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg035"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1787\/c263c014-en"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2019.04.003"},{"key":"e_1_3_4_70_1","doi-asserted-by":"crossref","unstructured":"Gamba S Pertile P Righetti G. Pricing Without borders: spillovers of external reference pricing in pharmaceutical regulation [Internet]. 2025 [cited 2026 May 14]. Report No.: 5381635. Available from: https:\/\/papers.ssrn.com\/abstract=5381635","DOI":"10.2139\/ssrn.5381635"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2026.2719624","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14737167.2026.2719624","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2026.2719624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:03:48Z","timestamp":1788411828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2026.2719624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":69,"alternative-id":["10.1080\/14737167.2026.2719624"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2026.2719624","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-06-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}